ANXA1-mediated mTOR/FABP4 Inhibition Drives Antifibrotic Macrophage Reprogramming in Lupus Nephritis
Abstract
macrophages in renal fibrosis progression, offering novel therapeutic targets for LN.
Fields of Study & Subjects
Systemic Lupus Erythematosus Research
Renal Diseases and Glomerulopathies
Chronic Kidney Disease and Diabetes
Publication details
- Journal / source
- International Journal of Biological Sciences
- Volume
- 22
- Issue
- 5
- Pages
- 2343–2360
- Publication date
- 4 February 2026
- Language
- EN